A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

Author: Fury Matthew   Solit David   Su Yungpo   Rosen Neal   Sirotnak F.   Smith Robert   Azzoli Christopher   Gomez Jorge   Miller Vincent   Kris Mark   Pizzo Barbara   Henry Roxanne   Pfister David   Rizvi Naiyer  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.59, Iss.4, 2007-03, pp. : 467-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content